 | Up a level |
Fennell, Dean A, Ewings, Sean, Ottensmeier, Christian 
ORCID: 0000-0003-3619-1657, Califano, Raffaele, Hanna, Gerard G, Hill, Kayleigh, Danson, Sarah, Steele, Nicola, Nye, Mavis, Johnson, Lucy et al (show 11 more authors)
(2021)
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
LANCET ONCOLOGY, 22 (11).
pp. 1530-1540.
Yuen, Hiu-Fung, Gunasekharan, Vignesh-Kumar ORCID: 0000-0002-2471-8485, Chan, Ka-Kui, Zhang, Shu-Dong ORCID: 0000-0002-7721-0167, Platt-Higgins, Angela, Gately, Kathy ORCID: 0000-0002-9616-424X, O'Byrne, Ken ORCID: 0000-0002-6754-5633, Fennell, Dean A, Johnston, Patrick G, Rudland, Philip S ORCID: 0000-0002-7491-0846 et al (show 1 more authors)
(2013)
RanGTPase: a candidate for Myc-mediated cancer progression.
Journal of the National Cancer Institute, 105 (7).
pp. 475-488.